Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Gepotidacin in Healthy Lactating Women
NCT07645235Phase 1Recruiting
- Sponsor
- GSK
- Start
- Jul 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of gepotidacin in urinary tract infection (UTI), sponsored by GSK. Primary endpoint: Area under the concentration-time curve from time zero to the last measurable concentration time point of gepotidacin in breast milk at 48 hours. Started Jul 2026; status: recruiting.
02
Drugs
gepotidacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07645235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645235.